The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
High-Sensitivity C-Reactive Protein, Lipoprotein-Associated Phospholipase A2, and Outcome After Ischemic Stroke
Abstract
BACKGROUND: Inflammatory markers have been associated with ischemic stroke risk and prognosis after cardiac events. Their relationship to prognosis after stroke is unsettled. METHODS: A population-based study of stroke risk factors in 467 patients with first ischemic stroke was undertaken to determine whether levels of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A(2) (Lp-PLA2) predict risk of stroke recurrence, other vascular events, and death. RESULTS: Levels of Lp-PLA2 and hs-CRP were weakly correlated (r = 0.09; P = .045). High-sensitivity CRP, but not Lp-PLA2, was associated with stroke severity. After adjusting for age, sex, race and ethnicity, history of coronary artery disease, diabetes mellitus, hypertension, hyperlipidemia, atrial fibrillation, smoking, and hs-CRP level, compared with the lowest quartile of Lp-PLA2, those in the highest quartile had an increased risk of recurrent stroke (adjusted hazard ratio, 2.08; 95% confidence interval, 1.04-4.18) and of the combined outcome of recurrent stroke, MI, or vascular death (adjusted hazard ratio, 1.86; 95% confidence interval, 1.01-3.42). After adjusting for confounders, hs-CRP was not associated with risk of recurrent stroke or recurrent stroke, myocardial infarction, or vascular death but was associated with risk of death (adjusted hazard ratio, 2.11; 95% confidence interval, 1.18-3.75). CONCLUSIONS: Inflammatory markers are associated with prognosis after first ischemic stroke and may offer complementary information. Lipoprotein-associated phospholipase A(2) may be a stronger predictor of recurrent stroke risk. Levels of hs-CRP, an acute-phase reactant, increase with stroke severity and may be associated with mortality to a greater degree than recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Adams, H. P., Davis, P. H., Leira, E. C., Chang, K.-C., Bendixen, B. H., Clarke, W. R., Woolson, R. F., & Hansen, M. D. (1999) · Neurology · doi:10.1212/wnl.53.1.126 · Cited by 1,456
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Collaborators, N. M. S. S., Sacco, R. L., Boden-Albala, B., Gan, R., Chen, X., Kargman, D. E., Shea, S., Paik, M. C., & Hauser, W. A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009445 · Cited by 721
Self-citationProinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke
Vila, N., Castillo, J., Dávalos, A., & Chamorro, A. (2000) · Stroke · doi:10.1161/01.str.31.10.2325 · Cited by 675
Ballantyne, C. M., Hoogeveen, R. C., Bang, H., Coresh, J., Folsom, A. R., Heiss, G., & Sharrett, A. R. (2004) · Circulation · doi:10.1161/01.cir.0000116763.91992.f1 · Cited by 613
Juhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke
Sacco, R. L. (1999) · JAMA · doi:10.1001/jama.281.1.53 · Cited by 531
Self-citationOei, H.-H. S., van der Meer, I. M., Hofman, A., Koudstaal, P. J., Stijnen, T., Breteler, M. M. B., & Witteman, J. C. M. (2005) · Circulation · doi:10.1161/01.cir.0000154553.12214.cd · Cited by 423
White blood cell count and cardiovascular disease. Insights from the Framingham Study
Kannel, W. B. (1992) · JAMA · doi:10.1001/jama.267.9.1253 · Cited by 365
Macphee, C. H., Moores, K., Boyd, H., Dhanak, D., Ife, R. J., Leach, C. A., Leake, D. S., Milliner, K. J., Patterson, R. A., Suckling, K. E., et al. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380479 · Cited by 359
The Behavioral Risk Factor Surveys: II. Design, Methods, and Estimates from Combined State Data
Gentry, E. M., Kalsbeek, W. D., Hogelin, G. C., Jones, J. T., Gaines, K. L., Forman, M. R., Marks, J. S., & Trowbridge, F. L. (1985) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)31372-2 · Cited by 338
C-Reactive Protein and Outcome After Ischemic Stroke
Muir, K. W., Weir, C. J., Alwan, W., Squire, I. B., & Lees, K. R. (1999) · Stroke · doi:10.1161/01.str.30.5.981 · Cited by 317
Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke
Di Napoli, M., Papa, F., & Bocola, V. (2001) · Stroke · doi:10.1161/01.str.32.1.133 · Cited by 315
Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events
Grau, A. J., Boddy, A. W., Dukovic, D. A., Buggle, F., Lichy, C., Brandt, T., & Hacke, W. (2004) · Stroke · doi:10.1161/01.str.0000124122.71702.64 · Cited by 308
Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Di Gianfilippo, G., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 289
Sacco, R. L., DeRosa, J. T., Haley, Jr., Levin, B., Ordronneau, P., Phillips, S. J., Rundek, T., Snipes, R. G., Thompson, J. L. P., & for the GAIN Americas Investigators (2001) · JAMA · doi:10.1001/jama.285.13.1719 · Cited by 283
Self-citationBallantyne, C. M., Hoogeveen, R. C., Bang, H., Coresh, J., Folsom, A. R., Chambless, L. E., Myerson, M., Wu, K. K., Sharrett, A. R., & Boerwinkle, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2479 · Cited by 280
Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke
Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S., & Silberger, J. R. (1995) · Annals of Neurology · doi:10.1002/ana.410370614 · Cited by 231
Brilakis, E. S., McConnell, J. P., Lennon, R. J., Elesber, A. A., Meyer, J. G., & Berger, P. B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi010 · Cited by 230
Prognostic Relevance of Early Serial C-Reactive Protein Measurements After First Ischemic Stroke
Winbeck, K., Poppert, H., Etgen, T., Conrad, B., & Sander, D. (2002) · Stroke · doi:10.1161/01.str.0000029828.51413.82 · Cited by 229
O’Donoghue, M., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Cannon, C. P., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.612630 · Cited by 229
Testing the validity of the lacunar hypothesis: The Northern Manhattan Stroke Study experience
Gan, R., Sacco, R. L., Kargman, D. E., Roberts, J. K., Boden-Albala, B., & Gu, Q. (1997) · Neurology · doi:10.1212/wnl.48.5.1204 · Cited by 190
Self-citationDi Napoli, M., & Papa, F. (2002) · Stroke · doi:10.1161/01.str.0000019124.54361.08 · Cited by 188
Arenillas, J. F., Álvarez-Sabín, J., Molina, C. A., Chacón, P., Montaner, J., Rovira, A., Ibarra, B., & Quintana, M. (2003) · Stroke · doi:10.1161/01.str.0000089920.93927.a7 · Cited by 188
Muhlestein, J. B., Horne, B. D., Carlquist, J. F., Madsen, T. E., Bair, T. L., Pearson, R. R., & Anderson, J. L. (2000) · Circulation · doi:10.1161/01.cir.102.16.1917 · Cited by 183
Elevated White Blood Cell Count and Carotid Plaque Thickness
Elkind, M. S. V., Cheng, J., Boden-Albala, B. M., Paik, M. C., & Sacco, R. L. (2001) · Stroke · doi:10.1161/01.str.32.4.842 · Cited by 144
Self-citationAssociations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke
Woodward, M., Lowe, G. D. O., Campbell, D. J., Colman, S., Rumley, A., Chalmers, J. P., Neal, B. C., Patel, A. A., Jenkins, A. J., Kemp, B. E., et al. (2005) · Stroke · doi:10.1161/01.str.0000181754.38408.4c · Cited by 129
Blackie, J. A., Bloomer, J. C., Brown, M. J. B., Cheng, H., Hammond, B., Hickey, D. M. B., Ife, R. J., Leach, C. A., Lewis, V. A., Macphee, C. H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00058-1 · Cited by 128
Schaefer, E. J., McNamara, J. R., Asztalos, B. F., Tayler, T., Daly, J. A., Gleason, J. L., SEMAN, L. J., Ferrari, A., & Rubenstein, J. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.023 · Cited by 115
Leukocyte count predicts outcome after ischemic stroke: The Northern Manhattan Stroke Study
Elkind, M. S. V., Cheng, J., Rundek, T., Boden-Albala, B. M., & Sacco, R. L. (2004) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2004.07.004 · Cited by 96
Self-citationRelative elevation in baseline leukocyte count predicts first cerebral infarction
Elkind, M. S. V., Sciacca, R. R., Boden-Albala, B. M., Rundek, T., Paik, M. C., & Sacco, R. L. (2005) · Neurology · doi:10.1212/01.wnl.0000165989.12122.49 · Cited by 83
Self-citationDesign of the trial of Org 10172 in acute stroke treatment (TOAST)
Adams, H. P., Woolson, R. F., Clarke, W. R., Davis, P. H., Bendixen, B. H., Love, B. B., Wasek, P. A., & Grimsman, K. J. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00012-3 · Cited by 65
Cited by
Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors
Grysiewicz, R. A., Thomas, K., & Pandey, D. K. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.07.003 · Cited by 473
Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley, W., Chong, W. L., Sengupta, A., & Sandercock, P. (2009) · Stroke · doi:10.1161/strokeaha.108.528752 · Cited by 290
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
Esenwa, C. C., & Elkind, M. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.125 · Cited by 281
Self-citationCopeptin: A novel, independent prognostic marker in patients with ischemic stroke
Katan, M., Fluri, F., Morgenthaler, N. G., Schuetz, P., Zweifel, C., Bingisser, R., Müller, K., Meckel, S., Gass, A., Kappos, L., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21783 · Cited by 267
C-reactive protein and Hypertension
Hage, F. G. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.111 · Cited by 205
Metadata
- Authors
- Elkind, M. S. V., Tai, W., Coates, K., Paik, M. C., & Sacco, R. L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-10-23
- Volume
- 166
- Issue
- 19
- Pages
- 2073
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2118801006
- Cited by
- 255
- References
- 42
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.